Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke

Sponsor
Chang Gung Memorial Hospital (Other)
Overall Status
Unknown status
CT.gov ID
NCT03960918
Collaborator
(none)
120
1
2
36
3.3

Study Details

Study Description

Brief Summary

Background: Stroke is a cerebrovascular disease which leads to ischemic damage of brain tissue and subsequent neurologic impairment. Aerobic capacity has become an effective prognosis for overall and cardiovascular mortality, but current protocols using in cardiopulmonary test (CPET) are not feasible for the hemiplegics due to balance or coordination deficit. The peak oxygen uptake should be underestimated for survival prediction. The calculation of the oxygen uptake efficiency slope (OUES) is independent of incremental exercise protocol, and patient effort, and is, therefore, suitable for patients who are not able or willing to attain maximal exercise values, just like stroke population.

Study Purpose: This project will enroll stroke patients to evaluate their aerobic capacity by CPET. Compared retrospectively with previous data from heart failure patients and healthy subjects, the investigators may know the aerobic capacity of stroke patients is underestimated or not. By collecting other parameters from exercise test (cardiac output and local tissue perfusion and oxygenation), the investigators could investigate the exercise intolerance of stroke patients is contributed from neurological origin mainly or several factors synergically.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: aerobic exercise therapy
N/A

Detailed Description

Background: Stroke is a cerebrovascular disease which leads to ischemic damage of brain tissue and subsequent neurologic impairment. Hence, the brain circulation is impaired after stroke which also play a possible cause for exercise intolerance not only neurogenic origin. The peak oxygen uptake in stroke patients was about half in healthy adults with the same age about 30 days after the disease occurrence. Aerobic capacity has become an effective prognosis for overall and cardiovascular mortality, but current protocols using in cardiopulmonary test (CPET) are not feasible for the hemiplegics due to balance or coordination deficit. The peak oxygen uptake should be underestimated for survival prediction. The calculation of the oxygen uptake efficiency slope (OUES) is independent of incremental exercise protocol, and patient effort, and is, therefore, suitable for patients who are not able or willing to attain maximal exercise values, just like stroke population. So it can be regarded as a single index of aerobic capacity that can be determined from submaximal exercise data. In healthy subjects, the OUES has a test-retest reliability similar to VO2peak (intra-class correlation coefficient (ICC) = 0.890 vs ICC = 0.910). The above properties make the OUES a possible alternative for VO2peak in patients with stroke who are unable to attain maximal exercise, and may provide clinicians with a better estimate of aerobic capacity in these patients.

Study purpose: This project will enroll stroke patients under new onset stage, late stage, and exercise intervention, to evaluate their aerobic capacity by CPET. Compared retrospectively with previous data from heart failure patients and healthy subjects, the investigators may know the aerobic capacity of stroke patients is underestimated or not. By collecting other parameters from exercise test (cardiac output and local tissue perfusion and oxygen), the investigators could investigate the exercise intolerance of stroke patients is contributed from neurological origin mainly or several factors synergically.

Methods: This is prospective (for stroke), randomized, parallel-group (for exercise) design with a 1:1 allocation ratio. 120 stroke patients will be randomly assigned to traditional rehabilitation training group(control) and traditional rehabilitation combined with aerobic training group (experiment). All enrolled subjects will perform a CPET before the training initiation. After CPET, the patients in the experimental group need to perform an additional bicycle training program with the intensity of 60 % maximal workload in the previous CPET (three days per week, for 12 weeks with a total of 36 times). When the training course completed, another CPET will be performed to evaluate the aerobic capacity again. In two CPET, a comprehensive cognitive and functional assessment will be also performed.

Measurable parameters: maximal oxygen uptake, maximal cardiac output, cerebral blood flow, oxygen uptake efficiency slope, limb muscle strength and function, and cognitive function was assessed.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
This is prospective (for stroke), randomized, parallel-group (for exercise) design with a 1:1 allocation ratio.This is prospective (for stroke), randomized, parallel-group (for exercise) design with a 1:1 allocation ratio.
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Validation of Oxygen Uptake Efficiency Slope in Patients With Stroke
Actual Study Start Date :
Jan 1, 2018
Anticipated Primary Completion Date :
Dec 30, 2020
Anticipated Study Completion Date :
Dec 31, 2020

Arms and Interventions

Arm Intervention/Treatment
No Intervention: usual neuro-rehab training

stroke patient under usual neuro-rehab training

Experimental: Novel exercise training

stroke patient under aerobic exercise training

Behavioral: aerobic exercise therapy
aerobic exercise therapy: All enrolled subjects will perform a CPET before the training initiation. After CPET, the patients in the experimental group need to perform an additional bicycle training program with the intensity of 60 % maximal workload in the previous CPET (five days per week, for four weeks with a total of 20 times).

Outcome Measures

Primary Outcome Measures

  1. physical fitness (peak oxygen consumption) [after 36 session exercise training, up to 12 weeks]

    oxygen consumption in cc/min/kg measured by Carefusion(TM) in CPET

  2. physical fitness (maximal cardiac output) [after 36 session exercise training, up to 12 weeks]

    maximal cardiac output in L/min measured by NICOM(TM) in CPET

  3. physical fitness(oxygen uptake efficiency slope) [after 36 session exercise training, up to 12 weeks]

    oxygen uptake efficiency slope was calculated with oxygen consumption and workload in CPET

  4. physical fitness (cerebral blood flow) [after 36 session exercise training, up to 12 weeks]

    cerebral blood flow in cc/min measured by Near-Infrared spectrometry

  5. physical fitness(limb muscle strength) [after 36 session exercise training, up to 12 weeks]

    limb muscle strength was measured by manual muscle test with (0-5) scales

Secondary Outcome Measures

  1. neuro-function(cognitive function) [after 36 session exercise training, up to 12 weeks]

    cognitive function was measured by MMSE ( Mini-Mental State Examination)

  2. neuro-function(limbs function) [after 36 session exercise training, up to 12 weeks]

    limbs function was measured by brunnstrom stage of stroke recovery with (1-6) scales

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Clinical diagnosis of Cerebrovascular accident, confirmed by a neurologist
Exclusion Criteria:

There are other diseases or behavioral restrictions that prevent exercise training, list below:

  1. dementia(MMSE<24), and etc.

  2. musculoskeletal disease

  3. Other exercise contraindications:

  4. unstable angina

  5. resting systolic blood pressure greater than 200 mmHg or diastolic blood pressure greater than 110 mmHg

  6. orthostatic blood pressure drop greater than 20 mmHg with symptoms

  7. Symptomatic severe aortic stenosis

  8. Acute systemic infection, accompanied by fever, body aches, or swollen lymph glands

  9. Uncontrolled cardiac dysrhythmias causing symptoms or hemodynamic compromise

  10. Uncontrolled symptomatic heart failure

  11. High-degree atrioventricular blocks

  12. Acute myocarditis or pericarditis

  13. Acute pulmonary embolus or pulmonary infarction

  14. a recent significant change in the resting electrocardiogram suggesting significant ischemia,

  15. recent myocardial infarction (within 2 d), or other acute cardiac events

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Physical Medicine and Rehabilitation of Keelung Chang Gung Memorial hospital Keelung Taiwan 204

Sponsors and Collaborators

  • Chang Gung Memorial Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier:
NCT03960918
Other Study ID Numbers:
  • 201600569B0
First Posted:
May 23, 2019
Last Update Posted:
Jan 6, 2020
Last Verified:
May 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Chang Gung Memorial Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 6, 2020